Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 38.50
-0.30 (-0.77%)
Aug 24, 2026, 3:16 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 595.16 million as of August 24, 2026. Its market cap has decreased by -32.30% in one year.
Market Cap
595.16M
Enterprise Value
532.63M
Revenue
182.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.50
ChartMarket Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 595.16M, an increase of 105.50%. That is a compound annual growth rate of 7.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 595.16M | -31.58% |
| Dec 30, 2025 | 869.82M | 43.88% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.50B |
| Thor Medical ASA | 2.41B |
| Circio Holding ASA | 2.19B |
| Nordhealth AS | 1.84B |
| Vistin Pharma ASA | 855.85M |
| INIFY Laboratories AB | 843.68M |
| Omda AS | 740.33M |
| Zelluna ASA | 655.93M |